Status:
COMPLETED
Evaluation of the PI-RADS v2.1 Score Using Multiple Readers
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Prostate Cancer
Urological Cancer
Eligibility:
MALE
Brief Summary
The interpretation of prostate multiparametric MRI (mpMRI) is difficult and requires expertise. As a result, it suffers from substantial inter-reader variability. The so-called Prostate Imaging Report...
Eligibility Criteria
Inclusion
- Prostate mpMRI and biopsy performed at our institution
- Performed between September 2015 and July 2016
- No history of prostate cancer at the time of the mpMRI
Exclusion
- Patients who already had treatment for prostate cancer
- Patients under Active Surveillance
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT04299997
Start Date
September 1 2019
End Date
June 30 2020
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Edouard Herriot
Lyon, France, 69008